Nicotine, alcohol and cocaine coupling to reward processes via endogenous morphine signaling: The dopamine-morphine hypothesis

Medical Science Monitor

Volumn 13, Issue 6, 2007, Pages

  Stefano, George B ^a   Bianchi, Enrica ^b   Guarna, Massimo ^b   Fricchione, Gregory L ^c   Zhu, Wei ^a   Cadet, Patrick ^a   Mantione, Kirk J ^a   Casares, Federico M ^a   Kream, Richard M ^d   Esch, Tobias ^e,f  

^a STATE UNIVERSITY OF NEW YORK   (United States)

^b UNIVERSITY OF SIENA   (Italy)

^c MASSACHUSETTS GENERAL HOSPITAL   (United States)

^d SUNY DOWNSTATE MEDICAL CENTER   (United States)

^e Department of Electrical Engineering and Computer Science   (Germany)

^f Institute for Integrative Medicine and Health Research   (Germany)

Author keywords

Addiction; Dopamine; Ethanol; Morphine; Motivation; Nicotine; Pleasure; Reward

Indexed keywords

ALCOHOL; ALPHA BUNGAROTOXIN; COCAINE; DOPAMINE; DOPAMINE RECEPTOR BLOCKING AGENT; EPIBATIDINE; MORPHINE; NICOTINE;

ALCOHOLISM; COCAINE DEPENDENCE; COGNITION; DOPAMINERGIC SYSTEM; HUMAN; LIMBIC SYSTEM; PRODUCTIVITY; REVIEW; SCHIZOPHRENIA; SOCIAL BEHAVIOR; TOBACCO DEPENDENCE;

ALCOHOLS; ANIMALS; COCAINE; HUMANS; MODELS, BIOLOGICAL; MORPHINE; NICOTINE; REWARD; SIGNAL TRANSDUCTION;

EID: 34249853774     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: None     Document Type: Review

References (197)

1. Bozarth MA: Pleasure systems in the brain. In: Wartburton DM, editors. Pleasure: The politics and the reality. New York, Wiley & Sons, 1994
2. Nestler EJ, Malenka RC: The addicted brain. Sci Am, 2004; 290: 78-85
3. Cannon CM, Bseikri MR: Is dopamine required for natural reward? Physiol Behav, 2004; 81: 741-48
4. Salamone JD: Will the last person who uses the term 'reward' please turn out the lights? Comments on processes related to reinforcement, learning, motivation and effort. Addict Biol, 2006; 11: 43-44
5. Esch T, Guarna M, Bianchi E et al: Commonalities in the central nervous system's involvement with complementary medical therapies: Limbic morphinergic processes. Med Sci Monit, 2004; 10(6): MS6-17
6. Esch T, Stefano GB: The neurobiology of pleasure, reward processes, addiction and their health implications. Neuroendocrinology Letters, 2004; 25: 235-51
7. Kream RM, Stefano GB: Morphine synthesis in animals. Med Sci Monit, 2006; 12(10): ED1-2
8. Zhu W, Pryor SC, Putnam J et al: Opiate alkaloids and nitric oxide production in the nematode Ascaris suum. J Parasitol, 2004; 90: 15-22
9. Salzet M, Stefano GB: The endocannabinoid system in invertebrates. Prostaglandins Leukotrienes & Essential Fatty Acids, 2002; 66: 353-61
10. Stefano GB, Fricchione GL, Slingsby BT, Benson H: The placebo effect and relaxation response: Neural processes and their coupling to constitutive nitric oxide. Brain Res Rev, 2001; 35: 1-19
11. Hui KKS, Liu J, Makris N et al: Acupuncture modulates the limbic system and subcortical gray structures of the human brain: Evidence from fMRI studies in normal subjects. Hum Brain Mapp, 2000; 9: 13-25
12. Esch T, Stefano GB, Fricchione GL, Benson H: The role of stress in neurodegenerative diseases and mental disorders. Neuroendocrinology Letters, 2002; 23: 199-208
13. Davidson RJ, Irwin W: The functional neuroanatomy of emotion and affective style. Trends Cogn Sci, 1999; 3: 11-21
14. Esch T: [Music medicine: Music in association with harm and healing]. Musikphysiol Musikermed, 2003; 10: 213-24
15. Nestler EJ: Molecular basis of long-term plasticity underlying addiction. Nat Rev Neurosci, 2001; 2: 119-28
16. Nestler EJ, Malenka RC, Hyman SE: Molecular basis of neuropharmacology. Columbus, McGraw-Hill, 2001
17. Stefano GB, Fricchione GL: The biology of deception: Emotion and morphine. Med Hypotheses, 1995; 49: 51-54
18. Bianchi E, Guarna M, Tagliamonte A: Immunocytochemical localization of endogenous codeine and morphine. Adv Neuroimmunol, 1994; 4: 83-92
19. Guarna M, Bianchi E, Bartolini A et al: Anti-mu opioid antiserum against the third external loop of the cloned mu opioid receptor acts as a mu receptor neutral antagonist. 2002
20. Stefano GB, Goumon Y, Casares F et al: Endogenous morphine. Trends Neurosci, 2000; 9: 436-42
21. Zhu W, Ma Y, Bell A et al: Presence of morphine in rat amygdala: Evidence for the mu3 opiate receptor subtype via nitric oxide release in limbic structures. Med Sci Monit, 2004; 10(12): BR433-39
22. Olds J: Drives and reinforcements: Behavioral studies of hypothalamic functions. New York, Raven Press, 1977
23. Wise RA: Catecholamine theories of reward: A critical review. Brain Res, 1978; 152: 215-47
24. Bozarth MA: Ventral tegmental reward system. In: Oreland L and Engel J (eds.) Brain reward systems and abuse. New York, Raven Press, 1987
25. Rodriguez dF, Navarro M: Role of the limbic system in dependence on drugs. Ann Med, 1998; 30: 397-405
26. Weiss F, Koob GF: Drug addiction: Functional neurotoxicity of the brain reward systems. Neurotox Res, 2001; 3: 145-56
27. Zhu W, Mantione KJ, Shen L et al: Norlaudanosoline and nicotine increase endogenous ganglionic morphine levels: Nicotine addiction. Cell Mol Neurobiol, 2006; 26: 1037-45
28. Troland LT: The fundamentals of human motivation. New York, Van Nostrand Reinhold, 1928
29. Esch T, Kim JW, Stefano GB: Neurobiological implications of eating healthy. Neuro Endocrinol Lett, 2006; 27
30. Salamon E, Esch T, Stefano GB: Pain and relaxation (review). Int J Mol Med, 2006; 18: 465-70
31. White NM, Milner PM: The psychobiology of reinforcers. Annu Rev Psychol, 1992; 43: 443-71
32. Stefano GB, Fricchione GL, Goumon Y, Esch T: Pain, immunity, opiate and opioid compounds and health. Med Sci Monit, 2005; 11(5): MS47-53
33. Everitt BJ, Robbins TW: Neural systems of reinforcement for drug addiction: from actions to habits to compulsion. Nat Neurosci, 2005; 8: 1481-89
34. Salamone JD, Correa M: Motivational views of reinforcement: implications for understanding the behavioral functions of nucleus accumbens dopamine. Behav Brain Res, 2002; 137: 3-25
35. Sanchis-Segura C, Spanagel R: Behavioural assessment of drug reinforcement and addictive features in rodents: an overview. Addict Biol, 2006; 11: 2-38
36. Berridge KC: Pleasures of the brain. Brain Cogn, 2003; 52: 106-28
37. Goldstein RZ, Volkow ND: Drug addiction and its underlying neurobiological basis: neuroimaging evidence for the involvement of the frontal cortex. Am J Psychiatry, 2002; 159: 1642-52
38. Mitchell JB, Stewart J: Facilitation of sexual behaviors in the male rat associated with intra-VTA injections of opiates. Pharmacol Biochem Behav, 1990; 35: 643-50
39. Esch T, Fricchione GL, Stefano GB: The therapeutic use of the relaxation response in stress-related diseases. Med Sci Monit, 2003; 9(2): RA23-34
40. Stefano GB, Esch T, Cadet P et al: Endocannabinoids as autoregulatory signaling molecules: Coupling to nitric oxide and a possible association with the relaxation response. Med Sci Monit, 2003; 9(4): RA63-75
41. Aung AT, Hickman NJ III, Moolchan ET: Health and performance related reasons for wanting to quit: Gender differences among teen smokers. Subst Use Misuse, 2003; 38: 1095-107
42. Botvin GJ, Griffin KW, Diaz T et al: Smoking initiation and escalation in early adolescent girls: One-year follow-up of a school-based prevention intervention for minority youth. J Am Med Womens Assoc, 1999; 54: 139-43, 152
43. Cachelin FM, Weiss JW, Garbanati JA: Dieting and its relationship to smoking, acculturation, and family environment in Asian and Hispanic adolescents. Eating Disorders: The Journal of Treatment and Prevention, 2003; 11: 51-61
44. Dzien A, Dzien-Bischinger C, Hoppichler F, Lechleitner M: The metabolic syndrome as a link between smoking and cardiovascular disease. Diabetes Obes Metab, 2004; 6: 127-32
45. Epstein JA, Botvin GJ, Spoth R: Predicting smoking among rural adolescents: Social and cognitive processes. Nicotine Tob Res, 2003; 5: 485-91
46. Gilman SE, Abrams DB, Buka SL: Socioeconomic status over the life course and stages of cigarette use: Initiation, regular use, and cessation. J Epidemiol Community Health, 2003; 57: 802-8
47. Jefferis B, Graham H, Manor O, Power C: Cigarette consumption and socio-economic circumstances in adolescence as predictors of adult smoking. Addiction, 2003; 98: 1765-72
48. Stangl V, Baumann G, Stangl K: Coronary atherogenic risk factors in women. Eur Heart J, 2002; 23: 1738-52
49. Yorulmaz F, Akturk Z, Dagdeviren N, Dalkilic A: Smoking among adolescents: Relation to school success, socioeconomic status nutrition and self-esteem. Swiss Med Wkly, 2002; 132: 449-54
50. Renaud SC, Beswick AD, Fehily AM et al: Alcohol and platelet aggregation: the Caerphilly Prospective Heart Disease Study. Am J Clin Nutr, 1992; 55: 1012-17
51. Takkouche B, Regueira-Mendez C, Garcia-Closas R et al: Intake of wine, beer, and spirits and the risk of clinical common cold. Am J Epidemiol, 2002; 155: 853-58
52. Truelsen T, Thudium D, Gronbaek M: Amount and type of alcohol and risk of dementia: the Copenhagen City Heart Study. Neurology, 2002; 59: 1313-19
53. Hoidrup S, Gronbaek M, Gottschau A et al: Alcohol intake, beverage preference, and risk of hip fracture in men and women. Copenhagen Centre for Prospective Population Studies. Am J Epidemiol, 1999; 149: 993-1001
54. Hamilton ME, Bozarth MA: Feeding elicited by dynorphin (1-13) microinjections into the ventral tegmental area in rats. Life Sci, 1988; 43: 941-46
55. Heath RG: Pleasure response of human subjects to direct stimulation of the brain. In: Heath RG (eds.) The Role of Pleasure in Human Behavior. New York, Hoeber, 1964
56. Stefano GB, Scharrer B: Endogenous morphine and related opiates, a new class of chemical messengers. Adv Neuroimmunol, 1994; 4: 57-68
57. Stefano GB, Scharrer B, Bilfinger TV et al: A novel view of opiate tolerance. Adv Neuroimmunol, 1996; 6: 265-77
58. Robinson TE, Berridge KC: Incentive-sensitization and addiction. Addiction, 2001; 96: 103-14
59. de la Fuente-Fernandez R, Schulzer M, Stoessl AJ: The placebo effect in neurological disorders. Lancet Neurol, 2002; 1: 85-91
60. McClung CA, Nestler EJ: Regulation of gene expression and cocaine reward by CREB and DeltaFosB. Nat Neurosci, 2003; 6: 1208-15
61. Zhang L, Lou D, Jiao H et al: Cocaine-induced intracellular signaling and gene expression are oppositely regulated by the dopamine D1 and D3 receptors. J Neurosci, 2004; 24: 3344-54
62. Hutcheson DM, Everitt BJ, Robbins TW, Dickinson A: The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci, 2001; 4: 943-47
63. Ahmed SH: Imbalance between drug and non-drug reward availability: a major risk factor for addiction. Eur J Pharmacol, 2005; 526: 9-20
64. Vanderschuren LJ, Everitt BJ: Behavioral and neural mechanisms of compulsive drug seeking. Eur J Pharmacol, 2005; 526: 77-88
65. Murphy CA, Russig H, Pezze MA et al: Amphetamine withdrawal modulates FosB expression in mesolimbic dopaminergic target nuclei: effects of different schedules of administration. Neuropharmacology, 2003; 44: 926-39
66. Nylander I, Vlaskovska M, Terenius L: The effects of morphine treatment and morphine withdrawal on the dynorphin and enkephalin systems in Sprague-Dawley rats. Psychopharmacology (Berl), 1995; 118: 391-400
67. Skoubis PD, Lam HA, Shoblock J et al: Endogenous enkephalins, not endorphins, modulate basal hedonic state in mice. Eur J Neurosci, 2005; 21: 1379-84
68. Green TA, Alibhai IN, Hommel JD et al: Induction of inducible cAMP early repressor expression in nucleus accumbens by stress or amphetamine increases behavioral responses to emotional stimuli. J Neurosci, 2006; 26: 8235-42
69. Kornetsky C: Brain-stimulation reward, morphine-induced oral stereotypy, and sensitization: implications for abuse. Neurosci Biobehav Rev, 2004; 27: 777-86
70. Thompson AC, Kristal MB: Opioids in the ventral tegmental area facilitate the onset of maternal behavior in the rat. Society for Neuroscience Abstracts, 1994; 18: 659
71. de la Fuente-Fernandez R, Ruth TJ, Sossi V et al: Expectation and dopamine release: mechanism of the placebo effect in Parkinson's disease. Science, 2001; 293: 1164-66
72. Spanagel R, Weiss F: The dopamine hypothesis of reward: past and current status. Trends Neurosci, 1999; 22: 521-27
73. Sapolsky RM: Stress and plasticity in the limbic system. Neurochem Res, 2003; 28: 1735-42
74. Esch T, Stefano GB: The Neurobiology of Love. Neuroendocrinology Letters, 2005; 26: 175-92
75. Summers CH, Korzan WJ, Lukkes JL et al: Does serotonin influence aggression? comparing regional activity before and during social interaction. Physiol Biochem Zool, 2005; 78: 679-94
76. Morgan D, Grant KA, Gage HD et al: Social dominance in monkeys: dopamine D2 receptors and cocaine self-administration. Nat Neurosci, 2002; 5: 169-74
77. Morgan D, Grant KA, Prioleau OA et al: Predictors of social status in cynomolgus monkeys (Macaca fascicularis) after group formation. Am J Primatol, 2000; 52: 115-31
78. Bozarth MA: The mesolimbic dopamine system as a model reward system. In: Willner P and Scheel-Krüger J (eds.) The Mesolimbic Dopamine System: From Motivation to Action. London, Wiley & Sons, 1991
79. Fibiger HC, Phillips AG: Dopamine and the neural mechanisms of reinforcement. In: Horn AS, Westerink BHC, Korf J (eds.) The Neurobiology of Dopamine. New York, Academic Press, 1979; 597-615
80. Esch T, Gesenhues S: [Terminology, classification and rational diagnostics in depression]. Psycho, 2002; 28: S21-27
81. Bozarth MA: New perspectives on cocaine addiction: Recent findings from animal research. Can J Physiol Pharmacol, 1989; 67: 1158-67
82. Rossetti ZL, Hmaidan Y, Gessa GL: Marked inhibition of mesolimbic dopamine release: A common feature of ethanol, morphine, cocaine and amphetamine abstinence in rats. Eur J Pharmacol, 1992; 221: 227-34
83. Wise RA, Bozarth MA: A psychomotor stimulant theory of addiction. Psychol Rev, 1987; 94: 469-92
84. Bozarth MA: Drug addiction as a psychobiological process. In: Wartburton DM, editors. Addiction Controversies. London: Harwood Academic Publishers, 1990
85. Zhu W, Mantione KJ, Shen L et al: Tyrosine and tyramine increase endogenous ganglionic morphine and dopamine levels in vitro and in vivo: CYP2D6 and tyrosine hydroxylase modulation demonstrates a dopamine coupling. Med Sci Monit, 2005; 11(11): BR397-404
86. Zhu W, Cadet P, Baggerman G et al: Human white blood cells synthesize morphine: CYP2D6 modulation. J Imumnol, 2005; 175: 7357-62
87. Kream RM, Stefano GB: De novo biosynthesis of morphine in animal cells: An evidence-based model. Med Sci Monit, 2006; 12(10): RA207-19
88. Pierce RC, Kumaresan V: The mesolimbic dopamine system: The final common pathway for the reinforcing effect of drugs of abuse? Neurosci Biobehav Rev, 2006; 30: 215-38
89. Larsson A, Engel JA: Neurochemical and behavioral studies on ethanol and nicotine interactions. Neurosci Biobehav Rev, 2004; 27: 713-20
90. Dohrman DP, Reiter CK: Chronic ethanol reduces nicotine-induced dopamine release in PC12 cells. Alcohol Clin Exp Res, 2003; 27: 1846-51
91. Larsson A, Svensson L, Soderpalm B, Engel JA: Role of different nicotinic acetylcholine receptors in mediating behavioral and neurochemical effects of ethanol in mice. Alcohol, 2002; 28: 157-67
92. Tizabi Y, Copeland RL Jr, Louis VA, Taylor RE: Effects of combined systemic alcohol and central nicotine administration into ventral tegmental area on dopamine release in the nucleus accumbens. Alcohol Clin Exp Res, 2002; 26: 394-99
93. Soderpalm B, Ericson M, Olausson P et al: Nicotinic mechanisms involved in the dopamine activating and reinforcing properties of ethanol. Behav Brain Res, 2000; 113: 85-96
94. Zhu W, Ma Y, Cadet P et al: Presence of reticuline in rat brain: A pathway for morphine biosynthesis. Mol Brain Res, 2003; 117: 83-90
95. Pai HV, Kommaddi RP, Chinta SJ et al: A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine. J Biol Chem, 2004; 279: 27383-89
96. Gasche Y, Daali Y, Fathi M et al: Codeine intoxication associated with ultrarapid CYP2D6 metabolism. N Engl J Med, 2004; 351: 2827-31
97. Amann T, Roos PH, Huh H, Zenk MH: Purification and characterization of a cytochrome P450 enzyme from pig liver, catalyzing the phenol oxidative coupling of (R)-reticuline to salutaridine, the critical step in morphine biosynthesis. Heterocycles, 1995; 40: 425-40
98. Funae Y, Kishimoto W, Cho T et al: CYP2D in the brain. Drug Metab Pharmacokinet, 2003; 18: 337-49
99. Hiroi T, Imaoka S, Funae Y: Dopamine formation from tyramine by CYP2D6. Biochem Biophys Res Commun, 1998; 249: 838-43
100. Lind AB, Wadelius M, Darj E et al: Gene expression of cytochrome P450 1B1 and 2D6 in leukocytes in human pregnancy. Pharmacol Toxicol, 2003; 92: 295-99
101. Touw DJ: Clinical implications of genetic polymorphisms and drug interactions mediated by cytochrome P-450 enzymes. Drug Metabol Drug Interact, 1997; 14: 55-82
102. Stefano GB, Zhao X, Bailey D et al: High affinity dopamine binding to mouse thymocytes and Mytilus edulis (Bivalvia) hemocytes. J Neuroimmunol, 1989; 21: 67-74
103. Cosentino M, Marino F, Bombelli R et al: Endogenous catecholamine synthesis, metabolism, storage and uptake in human neutrophils. Life Sci, 1999; 64: 975-81
104. Bergquist J, Silberring J: Identification of catecholamines in the immune system by electrospray ionization mass spectrometry. Rapid Commun Mass Spectrom, 1998; 12: 683-88
105. Basu S, Dasgupta PS: Dopamine, a neurotransmitter, influences the immune system. J Neuroimmunol, 2000; 102: 113-24
106. Stefano GB, Scharrer B, Smith EM et al: Opioid and opiate immunoregulatory processes. Crit Rev in Immunol, 1996; 16: 109-44
107. Stefano GB: Autoimmunovascular regulation: Morphine and anandamide stimulated nitric oxide release. J Neuroimmunol, 1998; 83: 70-76
108. Saurer TB, Carrigan KA, Ijames SG, Lysle DT: Morphine-induced alterations of immune status are blocked by the dopamine D2-like receptor agonist 7-OH-DPAT. J Neuroimmunol, 2004; 148: 54-62
109. Dani JA, Harris RA: Nicotine addiction and comorbidity with alcohol abuse and mental illness. Nat Neurosci, 2005; 8: 1465-70
110. Fricchione GL, Stefano GB: Placebo neural systems: Nitric oxide, morphine and the dopamine brain reward and motivation circuitries. Med Sci Monit, 2005; 11(5): MS54-65
111. Guarna M, Ghelardini C, Galeotti N et al: Neurotransmitter role of endogenous morphine in CNS. Med Sci Monit, 2005; 11(6): RA190-93
112. Pryor SC, Zhu W, Cadet P et al: Endogenous morphine: opening new doors for the treatment of pain and addiction. Expert Opin Biol Ther, 2005; 5: 893-906
113. de Haan L, Booij J, Lavalaye J et al: Occupancy of dopamine D2 receptors by antipsychotic drugs is related to nicotine addiction in young patients with schizophrenia. Psychopharmacology (Berl), 2006; 183: 500-5
114. Nakajima M, Yokoi T: Interindividual variability in nicotine metabolism: C-oxidation and glucuronidation. Drug Metab Pharmacokinet, 2005; 20: 227-35
115. Biala G, Weglinska B: On the mechanism of cross-tolerance between morphine- and nicotine-induced antinociception: Involvement of calcium channels. Prog Neuropsychopharmacol Biol Psychiatry, 2005
116. Biala G, Weglinska B: Calcium channel antagonists attenuate cross-sensitization to the rewarding and/or locomotor effects of nicotine, morphine and MK-801. J Pharm Pharmacol, 2004; 56: 1021-28
117. Grinevich VP, Crooks PA, Sumithran SP et al: N-n-alkylpyridinium analogs, a novel class of nicotinic receptor antagonists: selective inhibition of nicotine-evoked [3H] dopamine overflow from superfused rat striatal slices. J Pharmacol Exp Ther, 2003; 306: 1011-20
118. Brody AL, Mandelkern MA, Olmstead RE et al: Gene variants of brain dopamine pathways and smoking-induced dopamine release in the ventral caudate/nucleus accumbens. Arch Gen Psychiatry, 2006; 63: 808-16
119. Geng Y, Savage SM, Johnson LJ et al: Effects of nicotine on the immune response. I. Chronic exposure to nicotine impairs antigen receptor-mediated signal transduction in lymphocytes. Tox & Applied Pharm, 1995; 135: 268-78
120. Geng Y, Savage SM, Razani-Boroujerdi S, Sopori ML: Effects of nicotine on the immune response. II. Chronic nicotine treatment induces T cell anergy. J Immunol, 1996; 156: 2384-90
121. Savage SM, Donaldson LA, Cherian S et al: Effects of cigarette smoke on the immune response. II. Chronic exposure to cigarette smoke inhibits surface immunoglobulin- mediated responses in B cells. Tox & Applied Pharm, 1991; 111: 523-29
122. Sopori ML, Gairola CG, DeLucia AJ et al: Immune responsiveness of monkeys exposed chronically to cigarette smoke. Clin Immunol Immunopathol, 1985; 36: 338-44
123. Sopori ML, Cherian S, Chilukuri R, Shopp GM: Cigarette smoke causes inhibition of the immune response to intratracheally administered antigens. Tox & Applied Pharm, 1989; 97: 489-99
124. Sopori ML, Savage SM, Christner RF et al: Cigarette smoke and the immune response: mechanism of nicotine - induced immunosuppression. Adv Biosci, 1993; 86: 663-72
125. Sopori ML, Goud NS, Kaplan AM: Effects of tobacco smoke on the immune system. In: Dean JH, Luster MI, Munson AE et al: (eds.) Immunotoxicology and immunopharmacology. New York, Raven Press, 1994; 413-34
126. Zhu W, Stefano GB: Reticuline exposure to invertebrate ganglia increases endogenous morphine levels. Neuro Endocrinol Lett, 2004; 25: 323-30
127. Zhu W, Mantione KJ, Shen L, Stefano GB: In vivo and in vitro L-DOPA exposure increases ganglionic morphine levels. Med Sci Moni, 2005; 11(5): MS1-5
128. Zhu W, Ma Y, Stefano GB: Presence of isoquinoline alkaloids in molluscan ganglia. Neuroendocrinol Lett, 2002; 23: 329-34
129. Wright TJ, Huddart H: The nature of the acetylcholine and 5-hydroxytryptamine receptors in buccal smooth muscle of the pest slug Deroceras reticulatum. J Comp Physiol [B], 2002; 172: 237-49
130. Dowell C, Olivera BM, Garrett JE et al: Alpha-conotoxin PIA is selective for alpha6 subunit-containing nicotinic acetylcholine receptors. J Neurosci, 2003; 23: 8445-52
131. Lee CM, Lin JT, Hwang JC: Pharmacological properties of ACh receptors on the heart of the marine bivalve Meretrix lusoria. Chin J Physiol, 1998; 41: 19-24
132. Vehovszky A, Salanki J: Pharmacological characterization of postsynaptic potentials evoked in the bimodal pacemaker neuron of Helix pomatia L. Acta Physiol Hung, 1983; 62: 35-46
133. Hellwig G, Achazi RK: ACh and 5-HT induced changes in the concentration of cytosolic inositol trisphosphate (InsP3) and inositol bisphosphate (InsP2) in the ABRM of Mytilus edulis L. Comp Biochem Physiol C, 1991; 100: 343-48
134. Zhu W, Mantione KJ, Casares FM et al: Alcohol-, nicotine-, and cocaineevoked release of morphine from invertebrate ganglia: Model system for screening drugs of abuse. Med Sci Monit, 2006; 12(5): BR155-61
135. Zhu W, Mantione K, Kream RM, Stefano GB: Alcohol-, Nicotine-, and Cocaine-Evoked Release of Morphine from Human White Blood Cells: Substances of Abuse Actions Converge on Endogenous Morphine Release. Med Sci Monit, 2006; 12(11): BR350-54
136. Zhu W, Mantione KJ, Casares FM et al: Cholinergic regulation of endogenous morphine release from lobster nerve cord. Med Sci Monit, 2006; 12(9): BR295-301
137. Lummis SC, Sattelle DB: Binding of N-[propionyl-3H]propionylated alpha-bungarotoxin and L-[benzilic-4,4′-3H] quinuclidinyl benzilate to CNS extracts of the cockroach Periplaneta americana. Comp Biochem Physiol C, 1985; 80: 75-83
138. Zayas RM, Qazi S, Morton DB, Trimmer BA: Nicotinic-acetylcholine receptors are functionally coupled to the nitric oxide/cGMP-pathway in insect neurons. J Neurochem, 2002; 83: 421-31
139. Jumblatt JE, Marquis JK, Mautner HG: On the specificity of 125-I-alpha-bungarotoxin binding to axonal membranes. J Neurochem, 1981; 37: 392-400
140. Fossier P, Poulain B, Baux G, Tauc L: Both presynaptic nicotinic-like and muscarinic-like autoreceptors regulate acetylcholine release at an identified neuro-neuronal synapse of Aplysia. Pflugers Arch, 1988; 411: 345-52
141. Fu WM, Liou HC, Chen YH: Nerve terminal currents induced by auto-reception of acetylcholine release. J Neurosci, 1998; 18: 9954-61
142. Wilson DF, West AE, Lin Y: Inhibitory action of nicotinic antagonists on transmitter release at the neuromuscular junction of the rat. Neurosci Lett, 1995; 186: 29-32
143. Wilson DF, Thomsen RH: Effects of hexamethonium on transmitter release from the rat phrenic nerve. Neurosci Lett, 1992; 143: 79-82
144. Woods AS, Moyer SC, Wang HY, Wise RA: Interaction of chlorisondamine with the neuronal nicotinic acetylcholine receptor. J Proteome Res, 2003; 2: 207-12
145. Fisher M, Huangfu D, Shen TY, Guyenet PG: Epibatidine, an alkaloid from the poison frog Epipedobates tricolor, is a powerful ganglionic depolarizing agent. J Pharmacol Exp Ther, 1994; 270: 702-7
146. Bannon AW, Gunther KL, Decker MW: Is epibatidine really analgesic? Dissociation of the activity, temperature, and analgesic effects of (±)-epibatidine. Pharmacol Biochem Behav, 1995; 51: 693-98
147. Yogeeswari P, Sriram D, Ratan BT, Thirumurugan R: Epibatidine and its analogues as nicotinic acetylcholine receptor agonist: an update. Nat Prod Res, 2006; 20: 497-505
148. Nieto-Fernandez FE, Mattocks DW, Cavani F et al: Morphine coupling to invertebrate immunocyte nitric oxide release is dependent on intracellular calcium transients. Comp Biochem Physiol, 1999; 123: 295-99
149. Catapane EJ, Stefano GB, Aiello E: Pharmacological study of the reciprocal dual innervation of the lateral ciliated gill epithelium by the CNS of Mytilus edulis. J Exp Biol, 1978; 74: 101-13
150. Catapane EJ, Stefano GB, Aiello E: Neurophysiological correlates of the dopaminergic Cilio-inhibitory mechanism. J Exp Biol, 1979; 83: 315-23
151. Stefano GB, Catapane EJ, Stefano JM: Temperature dependent ciliary rhythmicity in Mytilus edulis and the effects of monoaminergic agents on its manifestation. Biol Bull, 1977; 153: 618-29
152. Aiello E, Hager E, Akiwumi C, Stefano GB: An opioid mechanism modulates central and not peripheral dopaminergic control of ciliary activity in the marine mussel Mytilus edulis. Cell Mol Neurobiol, 1986; 6: 17-30
153. Stefano GB, Catapane EJ, Aiello E: Dopaminergic agents: Influence on serotonin in the molluscan nervous system. Science, 1976; 194: 539-41
154. Davis VE, Walsh MJ: Alcohol, amines and alkaloids: a possible biochemical basis for alcohol addiction. Science, 1970; 167: 1005-7
155. Haber H, Roske I, Rottmann M et al: Alcohol induces formation of morphine precursors in the striatum of rats. Life Sciences, 1997; 60: 79-89
156. Ingvar M, Ghatan PH, Wirsen-Meurling A et al: Alcohol activates the cerebral reward system in man. J Stud Alcohol, 1998; 59: 258-69
157. Kreek MJ: Opioid interactions with alcohol. Adv Alcohol Subst Abuse, 1984; 3: 35-46
158. Rada P, Johnson DF, Lewis MJ, Hoebel BG: In alcohol-treated rats, naloxone decreases extracellular dopamine and increases acetylcholine in the nucleus accumbens: evidence of opioid withdrawal. Pharmacol Biochem Behav, 2004; 79: 599-605
159. DiChiara G, Acquas E, Carboni E: Dopamine and drug-induced motivation. In: Gessa GL, Serra G (eds.) Dopamine and Mental Depression. Oxford, Pergamon Press, 1990; 27-38
160. Nimit Y, Schulze I, Cashaw JL et al: Interaction of catecholamine-derived alkaloids with central neurotransmitter receptors. J Neurosci Res, 1983; 10: 175-89
161. Seevers MH, Davis VE, Walsh MJ: Morphine and ethanol physical dependence: a critique of a hypothesis. Science, 1970; 170: 1113-15
162. Cashaw JL, Geraghty CA, McLaughlin BR, Davis VE: Effect of acute ethanol administration on brain levels of tetrahydropapaveroline in L-dopa-treated rats. J Neurosci Res, 1987; 18: 497-503
163. Cardinale GJ, Donnerer J, Finck AD et al: Morphine and codeine are endogenous components of human cerebrospinal fluid. Life Sci, 1987; 40: 301-6
164. Donnerer J, Oka K, Brossi A et al: Presence and formation of codeine and morphine in the rat. Proc Natl Acad Sci USA, 1986; 83: 4566-67
165. Donnerer J, Cardinale G, Coffey J et al: Chemical characterization and regulation of endogenous morphine and codeine in the rat. J Pharmacol Exp Ther, 1987; 242: 583-87
166. Epple A, Navarro I, Horak P, Spector S: Endogenous morphine and codeine: release by the chromaffin cells of the eel. Life Sci, 1993; 52: PL117-21
167. Gintzler AR, Levy A, Spector S: Antibodies as a means of isolating and characterizing biologically active substances: Presence of a non-peptide morphine-like compound in the central nervous system. Proc Natl Acad Sci USA, 1976; 73: 2132-36
168. Kodaira H, Spector S: Transformation of thebaine to oripavine, codeine, and morphine by rat liver,kidney, and brain microsomes. Proc Natl Acad Sci USA, 1988; 85: 1267-71
169. Kodaira H, Listek CA, Jardine I et al: Identification of the convusant opiate thebaine in the mammalian brain. Proc Natl Acad Sci USA, 1989; 86: 716-19
170. Spector S, Kantrowitz JD, Oka K: Presence of endogenous morphine in toad skin. Prog Clin Biol Res, 1985; 192: 329-32
171. Spector S, Munjal I, Schmidt DE: Endogenous morphine and codeine. Possible role as endogenous anticonvulsants. Brain Res, 2001; 915: 155-60
172. Stefano GB, Digenis A, Spector S et al: Opiate-like substances in an invertebrate, an opiate receptor on invertebrate and human immunocytes, and a role in immunosuppression. Proc Natl Acad Sci USA, 1993; 90: 11099-103
173. Leung MK, Dissous C, Capron A et al: Schistosoma mansoni: The presence and potential use of opiate-like substances. Exp Parasit, 1995; 81: 208-15
174. Stefano GB, Leung MK, Bilfinger TV, Scharrer B: Effect of prolonged exposure to morphine on responsiveness of human and invertebrate immunocytes to stimulatory molecules. J Neuroimmunol, 1995; 63: 175-81
175. Allen S, Khan S, Al-Mohanna F et al: Native low density lipoprotein-induced calcium transients trigger VCAM-1 and E-selectin expression in cultured human vascular endothelial cells. J Clin Invest, 1998; 101: 1064-75
176. Zhu W, Cadet P, Mantione KJ et al: Response to Comment on "Human White Blood Cells Synthesize Morphine: CYP2D6 Modulation". J Immunol, 2006; 176: 5704
177. Goumon Y, Casares F, Zhu W, Stefano GB: The presence of morphine in ganglionic tissues of Modiolus deminissus: A highly sensitive method of quantitation for morphine and its derivatives. Mol Brain Res, 2001; 86: 184-88
178. Goumon Y, Casares F, Pryor S et al: Ascaris suum, an internal parasite, produces morphine. J Immunol, 2000; 165: 339-43
179. Stefano GB, Cadet P, Rialas CM et al: Invertebrate Opiate Immune and Neural Signaling. In: Machelska H, Stein C (eds.) Immune Mechanisms of Pain and Analgesia. New York, NY, Plenum Publ., 2003; 126-47
180. Belkowski SM, Zhu J, Liu-Chen LY et al: Detection of kappa-opioid receptor mRNA in immature T cells. Adv Exp Med Biol, 1995; 373: 11-16
181. Zhu W, Baggerman G, Secor WE et al: Dracunculus medinensis and Schistosoma mansoni contain opiate alkaloids. Ann Trop Med Parasitol, 2002; 96: 309-16
182. Boettcher C, Fellermeier M, Boettcher C et al: How human neuroblastoma cells make morphine. Proc Natl Acad Sci USA, 2005; 102: 8495-500
183. Poeaknapo C, Schmidt J, Brandsch M et al: Endogenous formation of morphine in human cells. Proc Natl Acad Sci USA, 2004; 101: 14091-96
184. Zhu W, Baggerman G, Goumon Y et al: Identification of morphine and morphine-6-glucuronide in the adrenal medullary chromaffin PC-12 cell line by nano electrospray ionization double quadrupole orthogonal acceleration time of flight mass spectrometry. Eur J of Mass Spect, 2001; 7: 25-28
185. Stefano GB, Braham E, Sinisterra JI et al: The effects of cocaine on peripheral monoaminergic regulatory mechanisms in the gill of Mytilus edulis. Symposia Biologica Hungarica, 1988; 36: 51-62
186. Wu X, Gu HH: Cocaine affinity decreased by mutations of aromatic residue phenylalanine 105 in the transmembrane domain 2 of dopamine transporter. Mol Pharmacol, 2003; 63: 653-58
187. Jayanthi LD, Apparsundaram S, Malone MD et al: The Caenorhabditis elegans gene T23G5.5 encodes an antidepressant- and cocaine-sensitive dopamine transporter. Mol Pharmacol, 1998; 54: 601-9
188. Altenmuller EO: [Apollo in us: How the brain processes music]. Musikphysiol Musikermed, 2002; 9: 24
189. Stefano GB, Fricchione GL, Esch T: Relaxation: Molecular and physiological significance. Med Sci Monit, 2006; 12(9): HY21-31
190. Guarna M, Neri C, Petrioli F, Bianchi E: Potassium-induced release of endogenous morphine form rat brain slices. J Neurochem, 1998; 70: 147-52
191. Guarna M, Bianchi E, Bartolini A et al: Endogenous morphine modulates acute thermonociception in mice. J Neurochem, 2002; 80: 271-77
192. Bianchi E, Alessandrini C, Guarna M, Tagliamonte A: Endogenous codeine and morphine are stored in specific brain neurons. Brain Res, 1993; 627: 210-15
193. de la Torre JC, Pappas BA, Prevot V et al: Hippocampal nitric oxide upregulation precedes memory loss and A beta I-40 accumulation after chronic brain hypoperfusion in rats. Neurological Research, 2003; 25: 635-41
194. Stefano GB, Goumon Y, Bilfinger TV et al Basal nitric oxide limits immune, nervous and cardiovascular excitation: Human endothelia express a mu opiate receptor. Prog Neurobiol, 2000; 60: 513-30
195. Vetulani J: Drug addiction. Part II. Neurobiology of addiction. Pol J Pharmacol, 2001; 53: 303-17
196. Routtenberg A, Lindy J: Effects of the availability of rewarding septal and hypothalamic stimulation on bar pressing for food under conditions of deprivation. J Comp Physiol Psychol, 1965; 60: 158-61
197. Fricchione GL, Mendoza A, Stefano GB: Morphine and its psychiatric implications. Adv Neuroimmunol, 1994; 4: 117-32